相关实验视频

Updated: May 10, 2026

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

儿科心脏瘤:全国人口研究

K Craig¹, J Patel¹, D Murphy²

¹Department of Paediatric Cardiology, Royal Hospital for Children, Glasgow, UK.

Pediatric cardiology

|May 14, 2025

概括

儿科心脏狂肌瘤,通常与结核性硬化综合体 (TSC) 相关,是最常见的心脏瘤. 早期识别和针对性治疗,如mTOR抑制剂,可以改善受影响儿童的结果.

科学领域:

心脏病学心脏病学
遗传学是一个遗传学.
在瘤学瘤学.

背景情况:

儿科心脏瘤很少见,最常见的是骨瘤,通常与结核性硬化综合体 (TSC) 相关.
TSC是一种由TSC1或TSC2基因变异引起的遗传疾病,导致潜在的心脏并发症,如心律失常和血流受阻.

研究的目的:

分析了23年的儿科心脏瘤的特征和结果.
调查瘤类型,TSC和临床表现之间的关联.
评估针对良性心脏瘤的向治疗的有效性.

主要方法:

一项对患有心脏瘤的患者进行了为期23年的回顾性研究,该研究被提交给了苏格兰国家儿童心脏病学服务.
分析瘤类型,患者人口统计,遗传关联 (TSC1/TSC2),心律失常和治疗方式.
统计分析以确定显著的关联 (例如,TSC中的皮瘤,心脏外症状).

主要成果:

确定了51种儿科心脏瘤,93.6%是良性的.
拉布多米奥马是最常见的整体瘤类型和TSC患者中最常见的瘤类型 (p = 0.000861).
18%的良性瘤有记录的心律失常,TSC亚型表现出显著的心脏外症状负担 (p = 0.00105),特别是TSC2相关的脏和神经问题.

结论:

儿科心脏狂肌瘤,特别是与TSC相关的,由于潜在的并发症,需要谨慎管理.
有效的向疗法,包括mTOR抑制剂用于牙瘤和β-阻断剂用于血液瘤.
对TSC家庭的遗传咨询对于了解长期的发病率和死亡率风险至关重要,特别是在TSC2病例中.

关键词:

心脏瘤的心脏瘤心声回声扫描 (Echocardiography) 是一种心声回声扫描.儿科儿科儿科拉布多米奥马 (Rhabdomyomas) 是一种表皮瘤.结核性硬化 - 结核性硬化

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...